Change Font Size: A A A A

Home | About Diabetes | About Riomet | Riomet Clinical Data | Safety Information | Diabetes Links | Healthcare Professionals
Bullet Some facts about Diabetes
Bullet Know basics of diabetes
Bullet What is Type 2 diabetes?
Bullet Take control of your Type 2 diabetes
Bullet How Metformin helps?
Bullet What are the consequences of high blood sugar?

Some facts about Diabetes

According to estimates by National Institute of Diabetes and digestive and kidney diseases, there were around 20.8 million people (7% of the US population) with diabetes in 2005. Out of these, around 14.6 million were diagnosed and rest was undiagnosed.

Roughly 9.6% (20.6 million) of all the people in the age group of 20 years and above in US have diabetes and this figure goes up to 20.9% (10.3 million) for people above 60 years.

Out of the total population with diabetes in the age group of 20 years or older, around 10.9 million are men and 9.7 million are women.

Some 176,500 people aged 20 years or younger are reported to be having diabetes which represents 0.22% of all people in this age group. Studies suggest that type 2 diabetes, although still rare, is being diagnosed more frequently in children and adolescents, particularly in American Indians, African Americans, and Hispanic/Latino Americans.

Source: http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm

 

Important Safety Information about RIOMET®

RIOMET as monotherapy, is indicated, as an adjunct to diet and exercise, to improve glycemic control in patients 10 years of age and older with type 2 diabetes. RIOMET may be used concomitantly with a sulfonylurea or insulin to improve glycemic control in adults (17 years of age and older).

RIOMET is contraindicated in patients with renal disease or dysfunction, acute or chronic metabolic acidosis, including diabetic ketoacidosis or known hypersensitivity to Metformin hydrochloride.

RIOMET should be avoided in patients >= 80 years old (unless measured creatinine clearance is normal), with impaired hepatic function, excessive alcohol intake (chronic or acute), or in the presence of any condition associated with hypoxemia, dehydration, or sepsis.

Temporarily discontinue in patients receiving intravascular iodinated contrast materials for radiologic studies. Diarrhea, nausea, vomiting, abdominal bloating, anorexia, or flatulence may occur, especially during initiation of therapy.

Not recommended for pediatric patients (under 10 years of age) or pregnant women.

Hypoglycemia does not occur in patients receiving RIOMET alone under usual circumstances of use. Hypoglycemia could occur when caloric intake is deficient, when strenuous exercise is not compensated by caloric supplementation, or during concomitant use with other glucose-lowering agents (such as sulfonylureas and insulin) or ethanol.

Please see full Prescribing Information, including boxed WARNING regarding lactic acidosis

Please consult with your healthcare professional to see if RIOMET is right for you. The content of this Web site is not a substitute for professional medical advice and should not be interpreted as treatment recommendations or relied on for medical diagnosis or treatment.